pubmed-article:17312166 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17312166 | lifeskim:mentions | umls-concept:C0019704 | lld:lifeskim |
pubmed-article:17312166 | lifeskim:mentions | umls-concept:C0007634 | lld:lifeskim |
pubmed-article:17312166 | lifeskim:mentions | umls-concept:C0913092 | lld:lifeskim |
pubmed-article:17312166 | lifeskim:mentions | umls-concept:C0039215 | lld:lifeskim |
pubmed-article:17312166 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
pubmed-article:17312166 | lifeskim:mentions | umls-concept:C1705822 | lld:lifeskim |
pubmed-article:17312166 | lifeskim:mentions | umls-concept:C0348011 | lld:lifeskim |
pubmed-article:17312166 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:17312166 | pubmed:dateCreated | 2007-2-21 | lld:pubmed |
pubmed-article:17312166 | pubmed:abstractText | Infection of CD4+ T lymphocytes is enhanced by the capture and subsequent transfer of HIV-1 by dendritic cells (DCs) via the interaction with C-type lectins such as the DC-specific ICAM-grabbing nonintegrin (DC-SIGN). Numerous HIV-1 envelope-directed neutralizing Abs have been shown to successfully block the infection of CD4(+) T lymphocytes. In this study, we find that HIV-1-neutralized with the mAb 2F5 is more efficiently captured by immature monocyte-derived DCs (iMDDCs) and DC-SIGN-expressing Raji cells (Raji-DC-SIGN). Furthermore, a 2F5-neutralized virus captured by these cells was able to subsequently infect CD4+ T lymphocytes upon the release of HIV-1 from iMDDCs, thereby enhancing infection. We show that upon transfer via DC-SIGN-expressing cells, HIV-1 is released from immune-complexes with the Abs 2F5 and 4E10 (gp41-directed) and 2G12, 4.8D, and 1.7b (gp120-directed). The nonneutralizing V3-21 (V3 region of the gp120-directed) Ab enhanced HIV-1 infection upon capture and transfer via Raji-DC-SIGN cells, whereas no infection was observed with the neutralizing b12 Ab (gp120-directed), indicating that different Abs have variant effects on inhibiting HIV-1 transfer to CD4+ T lymphocytes. The increased capture of the 2F5-neutralized virus by iMDDCs was negated upon blocking the Fc receptors. Blocking DC-SIGN on iMDDCs resulted in a 70-75% inhibition of HIV-1 capture at 37 degrees C, whereas at 4 degrees C a full block was observed, showing that the observed transfer is mediated via DC-SIGN. Taken together, we propose that DC-SIGN-mediated capture of neutralized HIV-1 by iMDDCs has the potential to induce immune evasion from the neutralization effects of HIV-1 Abs, with implications for HIV-1 pathogenesis and vaccine development. | lld:pubmed |
pubmed-article:17312166 | pubmed:language | eng | lld:pubmed |
pubmed-article:17312166 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17312166 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:17312166 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17312166 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17312166 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17312166 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17312166 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17312166 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17312166 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17312166 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17312166 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17312166 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17312166 | pubmed:month | Mar | lld:pubmed |
pubmed-article:17312166 | pubmed:issn | 0022-1767 | lld:pubmed |
pubmed-article:17312166 | pubmed:author | pubmed-author:GeijtenbeekTe... | lld:pubmed |
pubmed-article:17312166 | pubmed:author | pubmed-author:PollakisGeorg... | lld:pubmed |
pubmed-article:17312166 | pubmed:author | pubmed-author:NabatovAlexey... | lld:pubmed |
pubmed-article:17312166 | pubmed:author | pubmed-author:PaxtonWilliam... | lld:pubmed |
pubmed-article:17312166 | pubmed:author | pubmed-author:van... | lld:pubmed |
pubmed-article:17312166 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:17312166 | pubmed:day | 1 | lld:pubmed |
pubmed-article:17312166 | pubmed:volume | 178 | lld:pubmed |
pubmed-article:17312166 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17312166 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17312166 | pubmed:pagination | 3177-85 | lld:pubmed |
pubmed-article:17312166 | pubmed:meshHeading | pubmed-meshheading:17312166... | lld:pubmed |
pubmed-article:17312166 | pubmed:meshHeading | pubmed-meshheading:17312166... | lld:pubmed |
pubmed-article:17312166 | pubmed:meshHeading | pubmed-meshheading:17312166... | lld:pubmed |
pubmed-article:17312166 | pubmed:meshHeading | pubmed-meshheading:17312166... | lld:pubmed |
pubmed-article:17312166 | pubmed:meshHeading | pubmed-meshheading:17312166... | lld:pubmed |
pubmed-article:17312166 | pubmed:meshHeading | pubmed-meshheading:17312166... | lld:pubmed |
pubmed-article:17312166 | pubmed:meshHeading | pubmed-meshheading:17312166... | lld:pubmed |
pubmed-article:17312166 | pubmed:meshHeading | pubmed-meshheading:17312166... | lld:pubmed |
pubmed-article:17312166 | pubmed:meshHeading | pubmed-meshheading:17312166... | lld:pubmed |
pubmed-article:17312166 | pubmed:meshHeading | pubmed-meshheading:17312166... | lld:pubmed |
pubmed-article:17312166 | pubmed:meshHeading | pubmed-meshheading:17312166... | lld:pubmed |
pubmed-article:17312166 | pubmed:meshHeading | pubmed-meshheading:17312166... | lld:pubmed |
pubmed-article:17312166 | pubmed:meshHeading | pubmed-meshheading:17312166... | lld:pubmed |
pubmed-article:17312166 | pubmed:meshHeading | pubmed-meshheading:17312166... | lld:pubmed |
pubmed-article:17312166 | pubmed:meshHeading | pubmed-meshheading:17312166... | lld:pubmed |
pubmed-article:17312166 | pubmed:year | 2007 | lld:pubmed |
pubmed-article:17312166 | pubmed:articleTitle | Efficient capture of antibody neutralized HIV-1 by cells expressing DC-SIGN and transfer to CD4+ T lymphocytes. | lld:pubmed |
pubmed-article:17312166 | pubmed:affiliation | Laboratory of Experimental Virology, Department of Medical Microbiology, Center of Infection and Immunity Amsterdam, Academic Medical Center of the University of Amsterdam, Meibergdreef 15, Amsterdam, The Netherlands. | lld:pubmed |
pubmed-article:17312166 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:17312166 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:17312166 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:17312166 | lld:entrezgene |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17312166 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17312166 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17312166 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17312166 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17312166 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17312166 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17312166 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17312166 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17312166 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17312166 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17312166 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17312166 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17312166 | lld:pubmed |